1. 2022
  2. Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma

    Moehler, M., Högner, A., Wagner, A. D., Obermannova, R., Alsina, M., Thuss-Patience, P., van Laarhoven, H. & Smyth, E., 1 Nov 2022, In: European Journal of Cancer. 176, p. 13-29 17 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Recurrent Disease After Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study

    Kalff, M. C., Henckens, S. P. G., Voeten, D. M., Heineman, D. J., Hulshof, M. C. C. M., van Laarhoven, H. W. M., Eshuis, W. J., Baas, P. C., Bahadoer, R. R., Belt, E. J. T., Brattinga, B., Claassen, L., Ćosović, A., Crull, D., Daams, F., van Dalsen, A. D., Dekker, J. W. T., van Det, M. J., Drost, M., van Duijvendijk, P., & 41 othersvan Esser, S., Gaspersz, M. P., Görgec, B., Groenendijk, R. P. R., Hartgrink, H. H., van der Harst, E., Haveman, J. W., Heisterkamp, J., van Hillegersberg, R., Kelder, W., Kingma, B. F., Koemans, W. J., Kouwenhoven, E. A., Lagarde, S. M., Lecot, F., van der Linden, P. P., Luyer, M. D. P., Nieuwenhuijzen, G. A. P., Olthof, P. B., van der Peet, D. L., Pierie, J-P. E. N., Pierik, E. G. J. M. R., Plat, V. D., Polat, F., Rosman, C., Ruurda, J. P., van Sandick, J. W., Scheer, R., Slootmans, C. A. M., Sosef, M. N., Sosef, O. V., de Steur, W. O., Stockmann, H. B. A. C., Stoop, F. J., Vugts, G., Vijgen, G. H. E. J., Weeda, V. O. B., Wiezer, M. J., van Oijen, M. G. H., van Berge Henegouwen, M. I. & Gisbertz, S. S., 1 Nov 2022, In: Annals of surgery. 276, 5, p. 806-813 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study

    Kroese, T. E., Jorritsma, N. K. N., van Laarhoven, H. W. M., Verhoeven, R. H. A., Mook, S., Haj Mohammad, N., Ruurda, J. P., van Rossum, P. S. N. & van Hillegersberg, R., 1 Nov 2022, In: Clinical and Translational Radiation Oncology. 37, p. 109-115 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

    Öcal, O., Schütte, K., Zech, C. J., Loewe, C., van Delden, O., Vandecaveye, V., Verslype, C., Gebauer, B., Sengel, C., Bargellini, I., Iezzi, R., Philipp, A., Berg, T., Klümpen, H. J., Benckert, J., Pech, M., Gasbarrini, A., Amthauer, H., Bartenstein, P., Sangro, B., & 3 othersMalfertheiner, P., Ricke, J. & Seidensticker, M., Nov 2022, In: European journal of nuclear medicine and molecular imaging. 49, 13, p. 4716-4726 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres

    Zandee, W. T., Merola, E., Poczkaj, K., de Mestier, L., Klümpen, H-J., Geboes, K., de Herder, W. W. & Munir, A., Nov 2022, In: European journal of cancer care. 31, 6, e13639.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer

    de Ruiter, B-M., van Hattum, J. W., Lipman, D., de Reijke, T. M., van Moorselaar, R. J. A., van Gennep, E. J., Maartje Piet, A. H., Donker, M., van der Hulle, T., Voortman, J., Oddens, J. R., Hulshof, M. C. C. M. & Bins, A. D., Nov 2022, In: European urology. 82, 5, p. 518-526 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy

    van den Bosch, T., Rueda, O. M., Caldas, C., Vermeulen, L. & Miedema, D. M., 19 Oct 2022, In: British journal of cancer. 127, 7, p. 1332-1339 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Team dynamics and clinician’s experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study

    Luijten, J. C. H. B. M., Westerman, M. J., Nieuwenhuijzen, G. A. P., Walraven, J. E. W., Sosef, M. N., Beerepoot, L. V., van Hillegersberg, R., Muller, K., Hoekstra, R., Bergman, J. J. G. H. M., Siersema, P. D., van Laarhoven, H. W. M., Rosman, C., Brom, L., Vissers, P. A. J. & Verhoeven, R. H. A., 18 Oct 2022, In: Frontiers in oncology. 12, 1003506.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX

    van Dijk, E., van Werkhoven, E., Asher, R., Mooi, J. K., Espinoza, D., van Essen, H. F., van Tinteren, H., van Grieken, N. C. T., Punt, C. J. A., Tebbutt, N. C. & Ylstra, B., 1 Oct 2022, In: International Journal of Cancer. 151, 7, p. 1166-1174 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Reply to W. Attaallah, A. Jain et al, and P. Mroczkowski et al

    Versteijne, E., van Dam, J. L., Besselink, M. G., Groot Koerkamp, B., Homs, M. Y. V., Wilmink, J. W., van Eijck, C. H. & van Tienhoven, G., 1 Oct 2022, In: Journal of clinical oncology. 40, 28, p. 3348-3350 3 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...148 Next

ID: 19925